Epiretinal membrane development during interferon treatment.
Kargi
Sebnem Hanioglu
SH
Ankara SSK Eye Hospital, Ankara, Turkey. sebnemkargi@yahoo.com
Oz
Ozay
O
Ustündağ
Yücel
Y
Firat
Esin
E
D000998:Antiviral Agents / Q000009:adverse effects*; D019773:Epiretinal Membrane / Q000139:chemically induced* / Q000175:diagnosis; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins